ABCL
Price
$2.44
Change
+$0.07 (+2.95%)
Updated
Jun 6 closing price
Capitalization
705.92M
65 days until earnings call
DNA
Price
$7.59
Change
+$0.36 (+4.98%)
Updated
Jun 6 closing price
Capitalization
423.19M
Interact to see
Advertisement

ABCL vs DNA

Header iconABCL vs DNA Comparison
Open Charts ABCL vs DNABanner chart's image
AbCellera Biologics
Price$2.44
Change+$0.07 (+2.95%)
Volume$3.8M
Capitalization705.92M
Ginkgo Bioworks Holdings
Price$7.59
Change+$0.36 (+4.98%)
Volume$1.51M
Capitalization423.19M
ABCL vs DNA Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. DNA commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and DNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ABCL: $2.04 vs. DNA: $7.42)
Brand notoriety: ABCL and DNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 62% vs. DNA: 103%
Market capitalization -- ABCL: $705.92M vs. DNA: $423.19M
ABCL [@Biotechnology] is valued at $705.92M. DNA’s [@Biotechnology] market capitalization is $423.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileDNA’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • DNA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABCL and DNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while DNA’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • DNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DNA is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +2.51% price change this week, while DNA (@Biotechnology) price change was +0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($706M) has a higher market cap than DNA($423M). DNA YTD gains are higher at: -24.440 vs. ABCL (-30.375). ABCL has higher annual earnings (EBITDA): -204.15M vs. DNA (-484.39M). ABCL has more cash in the bank: 626M vs. DNA (562M). ABCL has less debt than DNA: ABCL (65.4M) vs DNA (468M). DNA has higher revenues than ABCL: DNA (227M) vs ABCL (28.8M).
ABCLDNAABCL / DNA
Capitalization706M423M167%
EBITDA-204.15M-484.39M42%
Gain YTD-30.375-24.440124%
P/E RatioN/AN/A-
Revenue28.8M227M13%
Total Cash626M562M111%
Total Debt65.4M468M14%
TECHNICAL ANALYSIS
Technical Analysis
ABCLDNA
RSI
ODDS (%)
Bullish Trend 11 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
78%
Momentum
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
79%
MACD
ODDS (%)
Bullish Trend 11 days ago
78%
Bearish Trend 11 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 24 days ago
86%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 11 days ago
86%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+3.03%
CRSP - ABCL
61%
Loosely correlated
-0.92%
ABSI - ABCL
59%
Loosely correlated
+0.74%
RXRX - ABCL
59%
Loosely correlated
+0.11%
NTLA - ABCL
57%
Loosely correlated
+3.59%
BEAM - ABCL
57%
Loosely correlated
-0.88%
More

DNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNA has been loosely correlated with CRSP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DNA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNA
1D Price
Change %
DNA100%
+9.28%
CRSP - DNA
50%
Loosely correlated
-0.92%
ABCL - DNA
49%
Loosely correlated
+3.03%
NTLA - DNA
48%
Loosely correlated
+3.59%
EYPT - DNA
45%
Loosely correlated
+18.12%
RXRX - DNA
45%
Loosely correlated
+0.11%
More